scholarly article | Q13442814 |
P2093 | author name string | B L Svarstad | |
R B Curtin | |||
T H Keller | |||
P433 | issue | 3 | |
P921 | main subject | hemodialysis patient | Q126109077 |
P304 | page(s) | 307-16; discussion 317, 335 | |
P577 | publication date | 1999-06-01 | |
P1433 | published in | ANNA journal | Q27709052 |
P1476 | title | Hemodialysis patients' noncompliance with oral medications | |
P478 | volume | 26 |
Q37030734 | A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence |
Q33317616 | A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease |
Q35959075 | Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature |
Q36160297 | Association of race with cumulative exposure to statins in dialysis |
Q45901738 | Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study. |
Q37809838 | Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices |
Q34036349 | Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study |
Q34769765 | Depression in African-American patients with kidney disease. |
Q28482035 | Determinants of compliance behaviours among patients undergoing hemodialysis in Malaysia |
Q81718585 | Hyperphosphatemia in children receiving peritoneal dialysis--an educational program |
Q36764881 | Impact of race on cumulative exposure to antihypertensive medications in dialysis |
Q98945349 | Interventions Incorporating Therapeutic Alliance to Improve Hemodialysis Treatment Adherence in Black Patients with End-Stage Kidney Disease (ESKD) in the United States: A Systematic Review |
Q44763531 | Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments |
Q26774337 | Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review |
Q36947323 | Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics. |
Q36279054 | Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS |
Q90257340 | Phosphate-control adherence in hemodialysis patients: current perspectives |
Q37215972 | Predictors of nonadherence with blood pressure regimens in hemodialysis |
Q34998759 | Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents |
Q38545747 | Regular monthly prescription with knowledge of each medicine may improve drug adherence in hemodialysis patients |
Q34503699 | Summary adherence estimates do not portray the true incongruity between drug intake, nurse documentation and physicians' orders |
Q35998260 | The Quantitative Analgesic Questionnaire: A Tool to Capture Patient-Reported Chronic Pain Medication Use |
Search more.